New

Metastatic Pancreatic Cancer Treatment Market

2021

Metastatic Pancreatic Cancer Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, and Others); Application (Exocrine, and Endocrine); End Use (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography

| Report Code: TIPRE00023214 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Metastatic Pancreatic Cancer Treatment Market 2028 By : Treatment Type, Application, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Metastatic pancreatic cancer treatment Metastatic pancreatic cancer cells grow all over the body organs from the pancreas to the abdomen, liver, lungs, brain, and bones. The metastatic pancreatic cancer spreads too much in the body, which is difficult to remove by surgery. Chemotherapy is typically considered the primary option for metastatic pancreatic cancer treatment. A combination of different chemo drugs is also considered a better option for metastatic pancreatic cancer treatment. The patients and clinicians also prefer targeted therapy, radiation therapy, and immunotherapy in many cases for metastatic pancreatic cancer treatment. Besides, several imaging technologies such as MRI, CT, and ultrasound are also being used for the diagnosis of metastatic pancreatic cancer treatment.

MARKET SCOPE

The "Global Metastatic Pancreatic Cancer Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharamceutica industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Metastatic pancreatic cancer treatment market with detailed market segmentation by treatment type, application, end use, and geography. The report provides key statistics on the market status of the leading Metastatic pancreatic cancer treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on treatment type, the global Metastatic pancreatic cancer treatment market is segmented into chemotherapy, targeted therapy, radiation therapy, immunotherapy, others.
  •  On the basis of application, the market is segmented into exocrine, endocrine.
  •  On the basis of end use, the market is segmented into hospitals, clinics, ambulatory surgical centers, others.

MARKET DYNAMICS
Drivers

  •   Rise in the cases of diabetes which leads to metastatic cancer.
  •   Advancement in chemotherapy.
  •   Change in diet and lifestyle.

Restraints

  •   The low availability of therapies to cure the life-threatening disease is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Metastatic pancreatic cancer treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Metastatic pancreatic cancer treatment market in these regions.

IMPACT OF COVID-19 ON METASTATIC PANCREATIC CANCER TREATMENT MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Metastatic pancreatic cancer treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Metastatic pancreatic cancer treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Metastatic pancreatic cancer treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Metastatic pancreatic cancer treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  AbbVie, Inc.
  •  Amgen, Inc.
  •  AstraZeneca PLC
  •  Bayer AG
  •  Boehringer Ingelheim International GmbH
  •  BRISTOL-MYERS SQUIBB COMPANY
  •  Eli-Lilly and Company
  •  Hoffmann-La Roche AG
  •  JOHNSON & JOHNSON
  •  Merck & Co., Inc.

The Insight Partner's dediMetastatic pancreatic cancer treatmented research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Metastatic Pancreatic Cancer Treatment Market - By Treatment Type
1.3.2 Metastatic Pancreatic Cancer Treatment Market - By Application
1.3.3 Metastatic Pancreatic Cancer Treatment Market - By End Use
1.3.4 Metastatic Pancreatic Cancer Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. METASTATIC PANCREATIC CANCER TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. METASTATIC PANCREATIC CANCER TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. METASTATIC PANCREATIC CANCER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. METASTATIC PANCREATIC CANCER TREATMENT - GLOBAL MARKET OVERVIEW
6.2. METASTATIC PANCREATIC CANCER TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. METASTATIC PANCREATIC CANCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. TARGETED THERAPY
7.4.1. Overview
7.4.2. Targeted Therapy Market Forecast and Analysis
7.5. RADIATION THERAPY
7.5.1. Overview
7.5.2. Radiation Therapy Market Forecast and Analysis
7.6. IMMUNOTHERAPY
7.6.1. Overview
7.6.2. Immunotherapy Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. METASTATIC PANCREATIC CANCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. EXOCRINE
8.3.1. Overview
8.3.2. Exocrine Market Forecast and Analysis
8.4. ENDOCRINE
8.4.1. Overview
8.4.2. Endocrine Market Forecast and Analysis
9. METASTATIC PANCREATIC CANCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. AMBULATORY SURGICAL CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. METASTATIC PANCREATIC CANCER TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Metastatic Pancreatic Cancer Treatment Market Overview
10.1.2 North America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis
10.1.3 North America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Treatment Type
10.1.4 North America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Application
10.1.5 North America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By End Use
10.1.6 North America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Metastatic Pancreatic Cancer Treatment Market
10.1.6.1.1 United States Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.1.6.1.2 United States Metastatic Pancreatic Cancer Treatment Market by Application
10.1.6.1.3 United States Metastatic Pancreatic Cancer Treatment Market by End Use
10.1.6.2 Canada Metastatic Pancreatic Cancer Treatment Market
10.1.6.2.1 Canada Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.1.6.2.2 Canada Metastatic Pancreatic Cancer Treatment Market by Application
10.1.6.2.3 Canada Metastatic Pancreatic Cancer Treatment Market by End Use
10.1.6.3 Mexico Metastatic Pancreatic Cancer Treatment Market
10.1.6.3.1 Mexico Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.1.6.3.2 Mexico Metastatic Pancreatic Cancer Treatment Market by Application
10.1.6.3.3 Mexico Metastatic Pancreatic Cancer Treatment Market by End Use
10.2. EUROPE
10.2.1 Europe Metastatic Pancreatic Cancer Treatment Market Overview
10.2.2 Europe Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis
10.2.3 Europe Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Treatment Type
10.2.4 Europe Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Application
10.2.5 Europe Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By End Use
10.2.6 Europe Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Metastatic Pancreatic Cancer Treatment Market
10.2.6.1.1 Germany Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.2.6.1.2 Germany Metastatic Pancreatic Cancer Treatment Market by Application
10.2.6.1.3 Germany Metastatic Pancreatic Cancer Treatment Market by End Use
10.2.6.2 France Metastatic Pancreatic Cancer Treatment Market
10.2.6.2.1 France Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.2.6.2.2 France Metastatic Pancreatic Cancer Treatment Market by Application
10.2.6.2.3 France Metastatic Pancreatic Cancer Treatment Market by End Use
10.2.6.3 Italy Metastatic Pancreatic Cancer Treatment Market
10.2.6.3.1 Italy Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.2.6.3.2 Italy Metastatic Pancreatic Cancer Treatment Market by Application
10.2.6.3.3 Italy Metastatic Pancreatic Cancer Treatment Market by End Use
10.2.6.4 Spain Metastatic Pancreatic Cancer Treatment Market
10.2.6.4.1 Spain Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.2.6.4.2 Spain Metastatic Pancreatic Cancer Treatment Market by Application
10.2.6.4.3 Spain Metastatic Pancreatic Cancer Treatment Market by End Use
10.2.6.5 United Kingdom Metastatic Pancreatic Cancer Treatment Market
10.2.6.5.1 United Kingdom Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.2.6.5.2 United Kingdom Metastatic Pancreatic Cancer Treatment Market by Application
10.2.6.5.3 United Kingdom Metastatic Pancreatic Cancer Treatment Market by End Use
10.2.6.6 Rest of Europe Metastatic Pancreatic Cancer Treatment Market
10.2.6.6.1 Rest of Europe Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.2.6.6.2 Rest of Europe Metastatic Pancreatic Cancer Treatment Market by Application
10.2.6.6.3 Rest of Europe Metastatic Pancreatic Cancer Treatment Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Overview
10.3.2 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Treatment Type
10.3.4 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Metastatic Pancreatic Cancer Treatment Market
10.3.6.1.1 Australia Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.3.6.1.2 Australia Metastatic Pancreatic Cancer Treatment Market by Application
10.3.6.1.3 Australia Metastatic Pancreatic Cancer Treatment Market by End Use
10.3.6.2 China Metastatic Pancreatic Cancer Treatment Market
10.3.6.2.1 China Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.3.6.2.2 China Metastatic Pancreatic Cancer Treatment Market by Application
10.3.6.2.3 China Metastatic Pancreatic Cancer Treatment Market by End Use
10.3.6.3 India Metastatic Pancreatic Cancer Treatment Market
10.3.6.3.1 India Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.3.6.3.2 India Metastatic Pancreatic Cancer Treatment Market by Application
10.3.6.3.3 India Metastatic Pancreatic Cancer Treatment Market by End Use
10.3.6.4 Japan Metastatic Pancreatic Cancer Treatment Market
10.3.6.4.1 Japan Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.3.6.4.2 Japan Metastatic Pancreatic Cancer Treatment Market by Application
10.3.6.4.3 Japan Metastatic Pancreatic Cancer Treatment Market by End Use
10.3.6.5 South Korea Metastatic Pancreatic Cancer Treatment Market
10.3.6.5.1 South Korea Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.3.6.5.2 South Korea Metastatic Pancreatic Cancer Treatment Market by Application
10.3.6.5.3 South Korea Metastatic Pancreatic Cancer Treatment Market by End Use
10.3.6.6 Rest of Asia-Pacific Metastatic Pancreatic Cancer Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.3.6.6.2 Rest of Asia-Pacific Metastatic Pancreatic Cancer Treatment Market by Application
10.3.6.6.3 Rest of Asia-Pacific Metastatic Pancreatic Cancer Treatment Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Metastatic Pancreatic Cancer Treatment Market Overview
10.4.2 Middle East and Africa Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Treatment Type
10.4.4 Middle East and Africa Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Metastatic Pancreatic Cancer Treatment Market
10.4.6.1.1 South Africa Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.4.6.1.2 South Africa Metastatic Pancreatic Cancer Treatment Market by Application
10.4.6.1.3 South Africa Metastatic Pancreatic Cancer Treatment Market by End Use
10.4.6.2 Saudi Arabia Metastatic Pancreatic Cancer Treatment Market
10.4.6.2.1 Saudi Arabia Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.4.6.2.2 Saudi Arabia Metastatic Pancreatic Cancer Treatment Market by Application
10.4.6.2.3 Saudi Arabia Metastatic Pancreatic Cancer Treatment Market by End Use
10.4.6.3 U.A.E Metastatic Pancreatic Cancer Treatment Market
10.4.6.3.1 U.A.E Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.4.6.3.2 U.A.E Metastatic Pancreatic Cancer Treatment Market by Application
10.4.6.3.3 U.A.E Metastatic Pancreatic Cancer Treatment Market by End Use
10.4.6.4 Rest of Middle East and Africa Metastatic Pancreatic Cancer Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.4.6.4.2 Rest of Middle East and Africa Metastatic Pancreatic Cancer Treatment Market by Application
10.4.6.4.3 Rest of Middle East and Africa Metastatic Pancreatic Cancer Treatment Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Metastatic Pancreatic Cancer Treatment Market Overview
10.5.2 South and Central America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis
10.5.3 South and Central America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Treatment Type
10.5.4 South and Central America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Application
10.5.5 South and Central America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Metastatic Pancreatic Cancer Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Metastatic Pancreatic Cancer Treatment Market
10.5.6.1.1 Brazil Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.5.6.1.2 Brazil Metastatic Pancreatic Cancer Treatment Market by Application
10.5.6.1.3 Brazil Metastatic Pancreatic Cancer Treatment Market by End Use
10.5.6.2 Argentina Metastatic Pancreatic Cancer Treatment Market
10.5.6.2.1 Argentina Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.5.6.2.2 Argentina Metastatic Pancreatic Cancer Treatment Market by Application
10.5.6.2.3 Argentina Metastatic Pancreatic Cancer Treatment Market by End Use
10.5.6.3 Rest of South and Central America Metastatic Pancreatic Cancer Treatment Market
10.5.6.3.1 Rest of South and Central America Metastatic Pancreatic Cancer Treatment Market by Treatment Type
10.5.6.3.2 Rest of South and Central America Metastatic Pancreatic Cancer Treatment Market by Application
10.5.6.3.3 Rest of South and Central America Metastatic Pancreatic Cancer Treatment Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL METASTATIC PANCREATIC CANCER TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. METASTATIC PANCREATIC CANCER TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ABBVIE, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN, INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAYER AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BRISTOL-MYERS SQUIBB COMPANY
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ELI-LILLY AND COMPANY
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HOFFMANN-LA ROCHE AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. JOHNSON AND JOHNSON
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MERCK AND CO., INC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie, Inc.
2. Amgen, Inc.
3. AstraZeneca PLC
4. Bayer AG
5. Boehringer Ingelheim International GmbH
6. BRISTOL-MYERS SQUIBB COMPANY
7. Eli-Lilly and Company
8. Hoffmann-La Roche AG
9. JOHNSON & JOHNSON
10. Merck & Co., Inc.
11. Novartis AG
12. Pfizer, Inc.
13. SANOFI
14. Nantkwest Inc
15. BioLineRx Ltd
16. Celgene Corporation
TIPRE00023214
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.